FI823824L - Morfinanderivat - Google Patents

Morfinanderivat

Info

Publication number
FI823824L
FI823824L FI823824A FI823824A FI823824L FI 823824 L FI823824 L FI 823824L FI 823824 A FI823824 A FI 823824A FI 823824 A FI823824 A FI 823824A FI 823824 L FI823824 L FI 823824L
Authority
FI
Finland
Prior art keywords
morfinanderivat
Prior art date
Application number
FI823824A
Other languages
English (en)
Finnish (fi)
Other versions
FI823824A0 (fi
FI823824A7 (fi
Inventor
Ernest Mohacsi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI823824A0 publication Critical patent/FI823824A0/fi
Publication of FI823824A7 publication Critical patent/FI823824A7/fi
Publication of FI823824L publication Critical patent/FI823824L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI823824A 1981-11-09 1982-11-08 Morfinanderivat FI823824L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/319,482 US4374139A (en) 1981-11-09 1981-11-09 Levorotatory N-substituted acylmorphinans useful as analgesic agents

Publications (3)

Publication Number Publication Date
FI823824A0 FI823824A0 (fi) 1982-11-08
FI823824A7 FI823824A7 (fi) 1983-05-10
FI823824L true FI823824L (fi) 1983-05-10

Family

ID=23242421

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823824A FI823824L (fi) 1981-11-09 1982-11-08 Morfinanderivat

Country Status (18)

Country Link
US (1) US4374139A (cs)
EP (1) EP0079556A3 (cs)
JP (1) JPS5888364A (cs)
KR (1) KR840002357A (cs)
AU (1) AU9027682A (cs)
CA (1) CA1195324A (cs)
DK (1) DK491582A (cs)
ES (2) ES517222A0 (cs)
FI (1) FI823824L (cs)
GR (1) GR78317B (cs)
HU (1) HU187425B (cs)
IL (1) IL67180A0 (cs)
MC (1) MC1490A1 (cs)
NO (1) NO823707L (cs)
NZ (1) NZ202404A (cs)
PH (1) PH18458A (cs)
PT (1) PT75815B (cs)
ZA (1) ZA827905B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423221A (en) * 1982-06-10 1983-12-27 Sisa Pharmaceutical Laboratories, Inc. 7-Carboethoxy-morphinan-6-one compounds
US4454141A (en) * 1982-09-23 1984-06-12 Sisa Pharmaceutical Laboratories, Inc. Trans-B/C-7-(1-hydroxypentyl)-3-methoxy-17 methyl-6,7-didehydromorphinans, and methods of relieving pain with them
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
DE4304450A1 (de) * 1993-02-13 1994-08-18 Boehringer Mannheim Gmbh System zur Zubereitung von Flüssigkeiten
WO2002036573A2 (en) * 2000-10-31 2002-05-10 Rensselaer Polytechnic Institute 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
PT2506712T (pt) 2009-12-04 2019-05-31 Alkermes Pharma Ireland Ltd Derivados de morfinano para o tratamento da overdose por fármaco
ES2582306T3 (es) 2010-03-22 2016-09-12 Rensselaer Polytechnic Institute Derivados de morfinano que contienen un grupo carboxamida como ligandos de receptores opioides
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
HUE034326T2 (en) 2011-06-29 2018-02-28 Alkermes Inc Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
JP2016519161A (ja) 2013-05-24 2016-06-30 アルカームス ファーマ アイルランド リミテッド モルファン及びモルフィナン類似物及び使用の方法
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
WO2018125716A1 (en) * 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723437A (en) * 1970-09-15 1973-03-27 American Home Prod 4,10-(methaniminomethano phenanthrene derivatives
ZA73988B (en) * 1972-03-10 1973-10-31 Hoffmann La Roche Morphinan derivatives
US3914233A (en) * 1972-10-20 1975-10-21 Hoffmann La Roche 4-Hydroxy-N-substituted morphinan derivatives

Also Published As

Publication number Publication date
KR840002357A (ko) 1984-06-25
ES8506635A1 (es) 1985-08-01
AU9027682A (en) 1983-05-19
IL67180A0 (en) 1983-03-31
ES8500948A1 (es) 1984-12-01
FI823824A0 (fi) 1982-11-08
EP0079556A2 (de) 1983-05-25
FI823824A7 (fi) 1983-05-10
MC1490A1 (fr) 1983-09-12
NZ202404A (en) 1985-11-08
PT75815A (en) 1982-12-01
GR78317B (cs) 1984-09-26
PH18458A (en) 1985-07-18
US4374139A (en) 1983-02-15
HU187425B (en) 1986-01-28
ZA827905B (en) 1983-08-31
EP0079556A3 (de) 1983-08-24
DK491582A (da) 1983-05-10
NO823707L (no) 1983-05-10
PT75815B (en) 1986-01-21
JPS5888364A (ja) 1983-05-26
CA1195324A (en) 1985-10-15
ES529349A0 (es) 1985-08-01
ES517222A0 (es) 1984-12-01

Similar Documents

Publication Publication Date Title
BE893795A (fr) Inhalateur-doseur
AT382116B (de) Geraeuschgedaempftes schienenrad
AT372860B (de) Schipaar
BE889765A (fr) Stijgerelement
BE893877A (fr) Mond-en tandverzorgingsmiddel
BE894481A (fr) Stromingsmeter
AT384100B (de) Drehrohrofen
BE891918A (fr) Draaibare schoorsteenkap
BE891837A (fr) Anthracycline-glycosides
AT379276B (de) Hoergeraet
AT385733B (de) Skibob
ATA183681A (de) Blockhaus
AT374656B (de) Maishaecksler
ATA243482A (de) Mauerstein
AT371306B (de) Hoergeraet
AT368631B (de) Zweibein
ATA492281A (de) Karniese
BE893123A (fr) Thienyl- et benzothienyl-t-butylamino-phenoxypropanols
AT374934B (de) Kapodaster
AR225979A1 (es) Tablestacado rompeolas
BR6100815U (pt) Gelobag
BR6100984U (pt) Caneta-lapiseira
ATA157781A (de) Steher
BR6100123U (pt) Lancabol
BR6100124U (pt) Dedobol

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO